09:55:26 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



V:KNE - Kane Biotech Inc. - http://www.kanebiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
KNE - V  11.00.13·0.1418.00.135+0.0053.843.8590.135  0.135  0.1250.17  0.0515:56:48Apr 2215 min RT 2¢
TSX-V - V11.00.13·0.1418.00.125-0.005-3.831.5440.135  0.135  0.1250.17  0.0515:44:5515 min
Alpha - A 0.135+0.0053.83.5010.135  0.135  0.13510:17:1715 min
Omega - O 0.135+0.0053.85.0110.135  0.135  0.13515:56:4815 min
Pure - P 0.130.051    Sep 1915 min
CX2 - H 0.125-0.005-3.83.5010.125  0.125  0.12515:44:5515 min
CXD - D 0.130.21    Oct 1615 min

Recent Trades - All 9 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:56:48O0.1350.0055,00084 ITG841 AnonymousK
15:44:55H0.125-0.0053,5001 Anonymous7 TD SecK
15:44:55V0.125-0.0058,5001 Anonymous7 TD SecK
13:42:14V0.13 8,0009 BMO Nesbitt7 TD SecK
13:42:14V0.13 10,00084 ITG847 TD SecK
10:17:17P0.1350.005509 BMO Nesbitt7 TD SecE
10:17:17A0.1350.0053,5009 BMO Nesbitt1 AnonymousK
09:30:00D0.13 2007 TD Sec7 TD SecE
09:30:00V0.1350.0055,00084 ITG841 AnonymousKL
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-22 19:37C:KNE0.14Property AgreementKane Biotech sale of Stem Animal interest
2024-04-16 15:23C:KNE0.14News ReleaseKane Biotech to hold webinar April 18
2024-04-15 14:44C:KNE0.125News ReleaseKane Biotech closes STEM interest sale
2024-04-11 10:02C:KNE0.15News ReleaseKane Biotech signs agreement in principle for Stem sale
2024-04-11 09:55C:KNE0.15Resume TradingKane Biotech to resume at 7:30 a.m. PT
2024-04-11 08:56C:KNE0.15Halt TradingKane Biotech halted at the open
2024-03-26 16:33C:KNE0.105News ReleaseKane Biotech loses $5.27-million in 2023
2024-03-26 16:28C:KNE0.105SEDAR MD & ASEDAR MD & A
2024-03-26 16:21C:KNE0.105SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-20 11:25C:KNE0.105News ReleaseKane extends exclusivity period on Stem offer
2024-03-19 16:14C:KNE0.105News ReleaseKane Biotech to release 2023 results March 26
2024-02-22 13:11C:KNE0.095News ReleaseKane Biotech appoints Huizinga as executive chair
2024-01-31 12:03C:KNENews ReleaseKane Biotech files revyve wound gel spray patent
2024-01-18 16:34C:KNE0.085News ReleaseKane Biotech to hold special meeting Feb. 20
2023-12-28 16:12C:KNE0.085News ReleaseKane Biotech extends Pivot credit line to March 31
2023-12-20 11:40C:KNE0.075News ReleaseKane Biotech to sell interest in STEM Animal Health
2023-11-28 16:24C:KNE0.075News ReleaseKane Biotech loses $1.44-million in Q3
2023-11-28 16:22C:KNE0.075SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-28 16:20C:KNE0.075SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-21 12:21C:KNE0.055News ReleaseKane Biotech to release Q3 2023 results Nov. 28